chr3-9810359-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001387446.1(TTLL3):c.-77C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,379,384 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000063 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00012 ( 0 hom. )
Consequence
TTLL3
NM_001387446.1 5_prime_UTR_premature_start_codon_gain
NM_001387446.1 5_prime_UTR_premature_start_codon_gain
Scores
16
Clinical Significance
Conservation
PhyloP100: -2.99
Genes affected
TTLL3 (HGNC:24483): (tubulin tyrosine ligase like 3) Enables protein-glycine ligase activity. Predicted to be involved in axoneme assembly and flagellated sperm motility. Predicted to be located in axoneme; microtubule cytoskeleton; and sperm flagellum. [provided by Alliance of Genome Resources, Apr 2022]
ARPC4-TTLL3 (HGNC:38830): (ARPC4-TTLL3 readthrough) This locus represents naturally occurring read-through transcription between the neighboring ARPC4 (actin related protein 2/3 complex, subunit 4) and TTLL3 (tubulin tyrosine ligase-like family, member 3) genes. The read-through transcript encodes a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.006790638).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTLL3 | NM_001387446.1 | c.-77C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/14 | ENST00000685419.1 | NP_001374375.1 | ||
TTLL3 | NM_001387446.1 | c.-77C>T | 5_prime_UTR_variant | 1/14 | ENST00000685419.1 | NP_001374375.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTLL3 | ENST00000685419 | c.-77C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/14 | NM_001387446.1 | ENSP00000510679.1 | ||||
TTLL3 | ENST00000685419 | c.-77C>T | 5_prime_UTR_variant | 1/14 | NM_001387446.1 | ENSP00000510679.1 | ||||
ARPC4-TTLL3 | ENST00000397256.5 | c.331-2584C>T | intron_variant | 5 | ENSP00000380427.1 |
Frequencies
GnomAD3 genomes AF: 0.0000630 AC: 6AN: 95268Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
6
AN:
95268
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000217 AC: 3AN: 13854Hom.: 0 AF XY: 0.000398 AC XY: 3AN XY: 7546
GnomAD3 exomes
AF:
AC:
3
AN:
13854
Hom.:
AF XY:
AC XY:
3
AN XY:
7546
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000117 AC: 150AN: 1284116Hom.: 0 Cov.: 70 AF XY: 0.000124 AC XY: 78AN XY: 627714
GnomAD4 exome
AF:
AC:
150
AN:
1284116
Hom.:
Cov.:
70
AF XY:
AC XY:
78
AN XY:
627714
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000630 AC: 6AN: 95268Hom.: 0 Cov.: 33 AF XY: 0.0000659 AC XY: 3AN XY: 45530
GnomAD4 genome
AF:
AC:
6
AN:
95268
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
45530
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.353C>T (p.P118L) alteration is located in exon 1 (coding exon 1) of the TTLL3 gene. This alteration results from a C to T substitution at nucleotide position 353, causing the proline (P) at amino acid position 118 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Vest4
MutPred
Loss of relative solvent accessibility (P = 0.008);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at